Skip To Main Content
Barbara Krug on Muck Rack

Barbara Krug

As seen in: Wiley Online Library, PLOS ONE
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy and safety of onasemnogene abeparvovec for the treatment of patients with spinal muscular atrophy type 1: A systematic review with meta-analysis

|
By Brígida Dias Fernandes, Barbara Krug, Porto Alegre
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Fernandes BD, Krug BC, Rodrigues FD, Cirilo HNC, Borges SS, Schwartz IVD, et al. (2024) Efficacy and safety of onasemnogene abeparvovec for the treatment of patients with spinal muscular atrophy type 1: A systematic review with meta-analysis. PLoS ONE 19(5): e0302860.
Open in Who Shared Issue with article?

Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma

|
By Jörg Fuchs Verified, Sarina K. Butzer, Barbara Krug, Maike Reisberg
| Wiley Online Library Verified
Abstract Background The pretreatment International Neuroblastoma Risk Group Staging System (INRGSS) discriminates localized tumors L1/L2 depending on the absence/presence of image-defined risk factors (IDRFs) at diagnosis. Referring to this new staging system, we assessed initial imaging of localized thoracic neuroblastoma (NB) and ganglioneuroma (GN) and the extent of initial tumor resection.
Open in Who Shared Issue with article?
See all 2 articles